Cipla said it would launch favipiravir as "Ciplenza" in the first week of August, priced at Rs 68 (91 cents) per 200 mg tablet.
from NDTV Profit - Latest https://ift.tt/3fUzrIi
from NDTV Profit - Latest https://ift.tt/3fUzrIi
Cipla Gets Regulatory Nod To Sell COVID-19 Drug
![Cipla Gets Regulatory Nod To Sell COVID-19 Drug]()
Reviewed by placements page
on
July 24, 2020
Rating:
No comments: